At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AKTX Akari Therapeutics PLC
Pre-Mkt 07-07 08:26:45 EDT
10.90
+0.49
+4.71%
盘前10.90
+0.000.00%
07:24 EDT
High11.65Low9.80Vol159.98K
Open9.80D1 Closing10.41Amplitude17.72%
Mkt Cap19.08MTradable Cap7.57MTotal Shares1.75M
T/O1.71MT/O Rate23.04%Tradable Shares694.50K
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Akari Therapeutics Publishes 2025 Annual Report
Reuters  ·  04:39
Akari Therapeutics Publishes 2025 Annual Report
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
MT Newswires Live  ·  07-06 23:21
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
Wall Street Analysts Are Bullish on Top Healthcare Picks
TIPRANKS  ·  07-06 16:20
Wall Street Analysts Are Bullish on Top Healthcare Picks
Akari Therapeutics Holds Annual General Meeting, Shareholders Vote on Director Re-elections
Reuters  ·  07-03
Akari Therapeutics Holds Annual General Meeting, Shareholders Vote on Director Re-elections
Akari Therapeutics - Prospectus Relates to Resale of up to 6 Mln Adss Representing 480 Bln Ordinary Shares by the Selling Shareholders - SEC Filing
THOMSON REUTERS  ·  07-03
Akari Therapeutics - Prospectus Relates to Resale of up to 6 Mln Adss Representing 480 Bln Ordinary Shares by the Selling Shareholders - SEC Filing
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
MT Newswires Live  ·  07-02
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
MT Newswires Live  ·  06-29
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
Akari Therapeutics Completes USD 5.5 Million PIPE Private Placement Financing
Reuters  ·  06-29
Akari Therapeutics Completes USD 5.5 Million PIPE Private Placement Financing
Press Release: Akari Therapeutics Completes Previously Announced PIPE, Strengthening Balance Sheet Ahead of Potential Key Clinical and Regulatory Milestones
Dow Jones  ·  06-29
Press Release: Akari Therapeutics Completes Previously Announced PIPE, Strengthening Balance Sheet Ahead of Potential Key Clinical and Regulatory Milestones
Akari Therapeutics - Files to Offer up to 2.5 Million Adss Via White Lion Capital - SEC Filing
Reuters  ·  06-27
Akari Therapeutics - Files to Offer up to 2.5 Million Adss Via White Lion Capital - SEC Filing
Akari Therapeutics Completes Sale of 980,395 Unregistered Adss in Private Placement
Reuters  ·  06-27
Akari Therapeutics Completes Sale of 980,395 Unregistered Adss in Private Placement
Akari Therapeutics - Files to Offer up to 2.5 Mln Adss Via White Lion Capital - SEC Filing
THOMSON REUTERS  ·  06-27
Akari Therapeutics - Files to Offer up to 2.5 Mln Adss Via White Lion Capital - SEC Filing
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
MT Newswires Live  ·  06-24
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Tuesday Trading
MT Newswires Live  ·  06-23
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Tuesday Trading
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
MT Newswires Live  ·  06-17
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading
MT Newswires Live  ·  06-15
European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading
European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week
MT Newswires Live  ·  06-12
European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week
Seven new option listings and one option delisting on June 12th
TIPRANKS  ·  06-12
Seven new option listings and one option delisting on June 12th
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
MT Newswires Live  ·  06-09
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Rise for Week
MT Newswires Live  ·  06-05
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Rise for Week

Introduction

Company Name.
Akari Therapeutics PLC
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities. The company also develops PASylated-nomacopan, which is in preclinical development for the treatment of geographic atrophy secondary to dry age-related macular degeneration; and hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) combined with nomacopan, which is in phase 3 clinical development for the treatment of pediatric HSCT-TMA. The company is headquartered in Boston, Massachusetts.
Issue price:
--